Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chronic Pain × Meloxicam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Pain, Postoperative 1 Lymphoma, Follicular 1 Hodgkin Disease 1 Chronic Pain 1 Acute Pain 1

Interventions

Morphine 7 Ketamine 5 Fentanyl 4 Sodium Chloride 3 Saline Solution 3 Lidocaine 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 Surveys and Questionnaires 2 Pregabalin 2 Mindfulness-Based Stress Reduction 2 Hypnosis 2 Bupivacaine 2 Acetaminophen 2 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Tramadol 1 Telemedicine 1 Tea 1 Tapentadol 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed

Lymphoma, Follicular, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡